CB
AMGN icon

Chemical Bank’s Amgen AMGN Stock Holding History

Chemical Bank’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.79M Buy
15,112
+1,080
+8% +$193K 0.32% 79
2019
Q1 		$2.67M Buy
14,032
+221
+2% +$42.2K 0.3% 75
2018
Q4 		$2.69M Buy
13,811
+85
+0.6% +$16.6K 0.33% 70
2018
Q3 		$2.85M Sell
13,726
-2,834
-17% -$559K 0.29% 78
2018
Q2 		$3.06M Buy
16,560
+1,420
+9% +$251K 0.33% 75
2018
Q1 		$2.58M Buy
15,140
+2,749
+22% +$505K 0.28% 84
2017
Q4 		$2.15M Buy
12,391
+410
+3% +$72.6K 0.23% 100
2017
Q3 		$2.23M Sell
11,981
-197
-2% -$34.9K 0.25% 96
2017
Q2 		$2.1M Buy
12,178
+858
+8% +$140K 0.23% 102
2017
Q1 		$1.86M Buy
11,320
+3,271
+41% +$544K 0.21% 115
2016
Q4 		$1.18M Buy
8,049
+431
+6% +$64.9K 0.13% 145
2016
Q3 		$1.27M Buy
7,618
+1,725
+29% +$292K 0.17% 122
2016
Q2 		$896K Hold
5,893
– – 0.12% 157
2016
Q1 		$883K Sell
5,893
-2,375
-29% -$353K 0.12% 155
2015
Q4 		$1.34M Sell
8,268
-232
-3% -$36.5K 0.19% 121
2015
Q3 		$1.18M Hold
8,500
– – 0.17% 135
2015
Q2 		$1.3M Sell
8,500
-50
-0.6% -$8.01K 0.17% 133
2015
Q1 		$1.37M Sell
8,550
-338
-4% -$53.2K 0.18% 133
2014
Q4 		$1.42M Buy
8,888
+935
+12% +$146K 0.18% 132
2014
Q3 		$1.12M Sell
7,953
-122
-2% -$15.9K 0.19% 116
2014
Q2 		$956K Sell
8,075
-75
-0.9% -$8.68K 0.16% 134
2014
Q1 		$1.01M Sell
8,150
-1,905
-19% -$231K 0.18% 127
2013
Q4 		$1.15M Sell
10,055
-200
-2% -$22.8K 0.2% 111
2013
Q3 		$1.15M Sell
10,255
-723
-7% -$78.4K 0.22% 106
2013
Q2 		$1.08M Buy
+10,978
New +$1.14M 0.21% 106

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chemical Bank's AMGN Position: Q2 2019 in Review

Chemical Bank increased its Amgen (AMGN) stake by 7.7% in Q2 2019, buying an estimated $193K and bringing the position to 15,112 shares worth $2.79M. The position accounts for 0.32% of the portfolio, ranked #79.

Chemical Bank first reported a position in AMGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $3.06M in Q2 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Chemical Bank held 15,112 shares of Amgen worth $2.79M as of Q2 2019.
  • Chemical Bank bought 1,080 Amgen shares in Q2 2019, an estimated $193K.
  • Amgen made up 0.32% of Chemical Bank's portfolio in Q2 2019, its #79 holding.
  • Chemical Bank first reported a position in Amgen in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's Amgen position peaked at $3.06M in Q2 2018.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.